))
Katie Capps on integrating pharmacogenomic testing into the CMM process
Manage episode 335750397 series 3351461
Content provided by GenXys Health Care Systems. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by GenXys Health Care Systems or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Katherine (Katie) Capps, Co-Founder & Executive Director of the GTMRx Institute as well as Founder & President of Health2 Resources, joined us in this episode of Precision Insights to discuss what comprehensive medication management (CMM) is, and how pharmacogenetics can be used in the CMM process.
40 episodes
Share
